SEC 13F Intelligence

Boxer Capital, LLC / ACAD

Boxer Capital, LLC’s Acadia Pharmaceuticals Inc Position

Does Boxer Capital, LLC own Acadia Pharmaceuticals Inc (ACAD)? Not currently — the last reported position was 1.26M shares worth $21M in Q3 2022; the fund’s latest 13F (Q4 2024) no longer reports it.

Position Value
$21M
Q3 2022
Shares
1.26M
% of Portfolio
+1.16%
Quarters Held
7
position exited

Position History ACAD

Reported value by quarter
Q1 ’20: $16MQ1 ’20Q2 ’20: $18MQ2 ’20Q3 ’20: $15MQ3 ’20Q4 ’21: $4MQ4 ’21Q1 ’22: $31MQ1 ’22Q2 ’22: $18MQ2 ’22Q3 ’22: $21MQ3 ’22filingsflow.com
QuarterSharesValue% of Portfolio
Q3 20221.26M$21M+1.16%
Q2 20221.26M$18M+1.13%
Q1 20221.26M$31M+1.57%
Q4 2021185.0K$4M+0.17%
Q3 2020370.0K$15M+0.53%
Q2 2020370.0K$18M+0.79%
Q1 2020370.0K$16M+1.07%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Boxer Capital, LLC’s full portfolio or all institutional holders of ACAD.